QIAGEN and EQT Private Equity agree on an all-cash public takeover offer for all outstanding QIAGEN shares at an off...
Qiagen has announced new artificial intelligence (AI) capabilities to help researchers analyse complex biological and ge...
QIAGEN N.V. has announced the launch of QIAmini, a compact automated sample preparation system designed to give research...
QIAGEN, a global provider of Sample to Insight solutions, has officially commenced a new distribution partnership with H...
Qiagen has announced that its QIAstat-Dx Meningitis/Encephalitis (ME) Panel has been included in the Australian Register...
Qiagen N.V. has announced new additions to its QIAcuity digital PCR (dPCR) ecosystem, with a focus on expanding gene exp...
Qiagen N.V. has announced its expansion into syndromic testing for bloodstream infections with the launch of the CE-IVDR...
A Gastrointestinal (GI) consensus meeting in Malaysia brought together leading gastroenterology experts from across the ...
The partnership between OGT, a global leader in genomic research and diagnostic solutions, and QIAGEN Digital ...
Qiagen N.V., headquartered in Netherlands, and US-based Incyte have announced a new global collaboration to develop a no...
Netherlands-based holding company Qiagen N.V. has announced the expansion of its oncology diagnostics portfolio with two...
Qiagen has announced a new commercial partnership and co-marketing agreement with ID Solutions, a French provider of hig...
Netherlands-headquartered Qiagen has signed a definitive agreement to acquire Israel-based Genoox, a provider of ar...
Qiagen N.V. has announced the launch of the QIAprep Plasmodium Kit and two companion assays to support malaria research ...
Qiagen has announced the official opening of a new data centre in Melbourne, Australia, designed to strengthen its globa...
Qiagen has partnered with Genomics England to support the delivery of the Generation Study. This first-of-its-kind initi...
Qiagen has announced the launch of two new tools for designing and ordering custom solutions that can be used to support...
QIAGEN today announced the inclusion of the QIAcuityDx digital PCR System in the Australian Register of Therapeutic...
Qiagen N.V. has announced the launch of the QIAcuityDx Digital PCR System, a pivotal addition to its digital PCR portfol...
Qiagen has announced the expansion of its strategic partnership with Bio-Manguinhos/Fiocruz, the leading provider of vac...
QIAGEN Singapore Pte. Ltd. has partnered with Parkway Laboratories, one of Singapore's leading clinical laboratories, to...
German firm Qiagen has announced the launch of its new digital PCR (dPCR) Custom Assay Design Tool for copy number varia...
Qiagen has introduced an improved version of its QIAstat-Dx Respiratory SARS-CoV-2 Panel in Malaysia, following approval...
German firm Qiagen has announced the launch of its QIAseq Multimodal DNA/RNA Lib Kit. The new kit enables seamless prepa...
Germany-headquartered company Qiagen has announced the availability of QCI Secondary Analysis, a cloud-based software-as...
